NANETS congratulates Claudius Conrad, MD, PhD of The University of Texas MD Anderson Cancer Center as the 2016 NANETS Clinical Investigator Scholarship recipient. The NCIS award focuses on supporting a clinical project as well as the investigator's potential to make future clinical contributions to the neuroendocrine tumor field. This award is in honor of Edda Gomez-Panzani, MD for her dedication and work on behalf of patients living with neuroendocrine tumors. The 2016 recipient, Dr. Claudius Conrad will continue his focus on the treatment of patients with pancreatic neuroendocrine tumors and neuroendocrine liver metastasis.

IPSEN is proud to sponsor the continuation of Edda’s work on behalf of NET patients through this Clinical Investigator Scholarship. IPSEN Biopharmaceuticals supports this research scholarship in the form of a $100,000 grant directed to NANETS to administer over the course of the two year grant period. The NANETS Research Committee establishes the award criteria, reviews process, and independently selects the recipient.